Suchergebnisse - "Pecquet, Christian"

PubPharm (58)

21

Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis

enthalten in: Blood | 2016

von Marty, C. | Pecquet, C. | Nivarthi, H. | +9

CommentIn: Blood. 2016 Mar 10;127(10):1219-21. - PMID 26965919

22

Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants

enthalten in: Blood | 2016

von Chachoua, I. | Pecquet, C. | El-Khoury, M. | +15

CommentIn: Blood. 2016 Mar 10;127(10):1219-21. - PMID 26965919

23

A Phenotypic Screen for Small-Molecule Inhibitors of Constitutively Active Mutant Thrombopoietin Receptor Implicated in Myeloproliferative Neoplasms

enthalten in: Combinatorial chemistry & high throughput screening | 2016

von Ngo, A. | Koay, A. | Pecquet, C. | +10

24

Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants

enthalten in: Blood | 2016

von Chachoua, I. | Pecquet, C. | El-Khoury, M. | +15

25

Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis

enthalten in: Blood | 2016

von Marty, C. | Pecquet, C. | Nivarthi, H. | +9

26

Cooperation of germ line JAK2 mutations E846D and R1063H in hereditary erythrocytosis with megakaryocytic atypia

enthalten in: Blood | 2016

von Kapralova, K. | Horvathova, M. | Pecquet, C. | +9

27

A phenotypic screen for small-molecule inhibitors of constitutively active mutant thrombopoietin receptor implicated in myeloproliferative neoplasms

enthalten in: Combinatorial chemistry & high throughput screening | 2016

von Ngo, A. | Koay, A. | Pecquet, C. | +10

28

Germ-line JAK2 mutations in the kinase domain are responsible for hereditary thrombocytosis and are resistant to JAK2 and HSP90 inhibitors

enthalten in: Blood | 2014

von Marty, C. | Saint-Martin, C. | Pecquet, C. | +15

29

Germ-line JAK2 mutations in the kinase domain are responsible for hereditary thrombocytosis and are resistant to JAK2 and HSP90 inhibitors

enthalten in: Blood | 2014

von Marty, C. | Saint-Martin, C. | Pecquet, C. | +15

30

Combination treatment for myeloproliferative neoplasms using JAK and pan-class I PI3K inhibitors

enthalten in: Journal of cellular and molecular medicine | 2013

von Choong, M. | Pecquet, C. | Pendharkar, V. | +10